GSK-3β inhibitor 26

Overview

GSK-3β inhibitor 26 (Compound D14) is a GSK-3β inhibitor with an IC 50 of 18.23 μM. GSK-3β inhibitor 26 can be used in the research of cancer , inflammation and neurodegenerative diseases.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > GSK-3

Product Information

• Catalog No.: HY-169602
• CAS No.: 70169-39-0
• Molecular Formula: C15H11N3O3
• Molecular Weight: 281.27
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source